RENSSELAER, N.Y., April 20, 2018 -- Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has been granted a license to the Easi-CRISPR technology from the University of Nebraska.
Easi-CRISPR was developed in the laboratories of Drs. Masato Ohtsuka (Tokai University in Japan), and Channabasavaiah Gurumurthy (University of Nebraska). The terms of the agreement include a world-wide, non-exclusive license to the technology, allowing Taconic rights to generate and sell rodent models generated via Easi-CRISPR. When compared to traditional CRISPR, Easi-CRISPR represents a significant advantage, allowing researchers to perform whole genetic insertions versus being limited to point mutations and constitutive knockouts.
“Easi-CRISPR is the next progression of the revolutionary CRISPR/Cas technology. Combining the speed of CRISPR with larger genetic insertions allows complex projects typically requiring homologous recombination techniques to reduce project timelines by six months. In an industry where time is a precious resource, access to this technology underscores Taconic’s commitment to providing our customers with the best solutions,” shared John Couse, vice president of scientific services of Taconic Biosciences.
Channabasavaiah Gurumurthy commented, “we are pleased to see the research community quickly adopting Easi-CRISPR. Licensing of Easi-CRISPR by Taconic, a globally recognized leader of animal model generation, should help scientists rapidly generate innovative models to benefit scientific research”.
Taconic is a fully-licensed provider of rodent model generation services and has over twenty years of model design experience. The company provides gene inactivation, gene mutation or replacement, transgene expression, RNAi, and gene editing via CRISPR/Cas9, pronuclear injection, and homologous recombination technologies to ensure that the right tools are leveraged for each specific customer project. Taconic's unique capability of providing a seamless transition from model design to breeding and colony management, offers customers a complete solution. These scientific solutions include acquiring or generating, importing, licensing, breeding, testing, preparing, and distributing genetically engineered models to any location worldwide.
To learn more about Taconic’s custom model generation, please call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email [email protected].
About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
Media Contact:
Kelly Owen Grover
Director of Marketing Communications
(518) 697-3824
[email protected]


Trump Buys SpaceX Shares After Record IPO
Bathla Group Hires Administrators as Australia Housing Slump Deepens
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Tesla Raises Cybertruck Prices by $5,000 in US
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny
OpenAI AI Agent Swarm Behind Hugging Face Hack
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
Mercer International Stock Surges 45% on C$20 Million Canada Funding 



